SOURCES SOUGHT
Q -- Specialized Laboratory Testing and Consultation Services
- Notice Date
- 4/24/2019
- Notice Type
- Synopsis
- NAICS
- 621511
— Medical Laboratories
- Contracting Office
- Department of Veterans Affairs;NETWORK 23 CONTRACTING OFFICE;316 Robert Street N. STE. 506;St. Paul MN 55101
- ZIP Code
- 55101
- Solicitation Number
- 36C26319R0016
- Response Due
- 5/22/2019
- Archive Date
- 7/6/2019
- Point of Contact
- daniel.vagts@va.gov
- Small Business Set-Aside
- N/A
- Description
- This is a sources sought announcement only. This is not a solicitation announcement. The purpose of this announcement is to gain knowledge of current market conditions relative to NAICS 621511 Medical Laboratory Testing with a size standard $32.5 million. The Department of Veterans Affairs (DVA), Network Contracting Office 23 (NCO 23), on behalf of Minneapolis VA Health Care System (MVAHCS), Minneapolis, MN is seeking to identify any vendors capable of providing contractual services of specialized laboratory testing and consultation services to eligible veteran beneficiaries of the MVAHCS. The period of performance will be one (1) twelve-month base year, and four (4) twelve-month option years. Background: Prior to issuing a solicitation, and pursuant to the Veterans First Contracting Program, the VA is trying to ascertain if there are qualified Service Disabled Veteran Owned Businesses (SDVOSB) or Veteran Owned Small Businesses (VOSB) with the capability of providing the below services (Respondents are not limited to SDVOSB/VOSB concerns; the Government seeks to identify ALL potentially interested sources): SCOPE: The Minneapolis VA Health Care System, hereinafter referred to as MVAHCS intends to secure a stat highly specialized laboratory testing and consultation services for the MVAHCS Pathology and Laboratory Medicine Service (P&LMS) located at One Veterans Drive, Minneapolis, MN 55417. All services provided shall be in accordance with the costs, terms and conditions of this contract. 2. CONTRACT TYPE AND TERM The VA will award a firm, fixed-price, indefinite delivery indefinite quantity commercial services contract for all items listed in the Schedule of Items. Contract use will be limited to the Minneapolis VA Medical Center only; no other VAMC may use this contract. The Base year effective period of the contract shall begin July 1, 2019 with the options to extend the contract for additional 12 month periods, at the discretion of the VA, for up to four (4) additional years. Total contract will not exceed five years. 3. STATEMENT OF WORK The MVAHCS, requires the services of a contractor to provide highly specialized and specific diagnostic testing needs not provided by the Minneapolis VA Health Care System. Testing needs may consist of but are not limited to stat and emergent drug levels and beta-2-tranferrin assays; quantitative cryoglobulin levels with identification; HLA typing; coagulation factor assays, consultation on complex anatomic pathology cases, including transplant pathology; and gross and microscopic neuropathology evaluations. See Schedule of items, 3.A., for more extensive list of required testing. The laboratory must be able to determine levels of the following on a stat or emergent basis: Amikacin Cyclosporine (by HPLC) Methotrexate Quinidine Sirolimus (by HPLC) Tacrolimus (by HPLC) Tobramycin Beta-2-transferrin Amytriptyline/Nortriptyline Everolimes Procain/NAPA Turn around Times for defined acceptable times of the STAT and emergent testing requirements. Turnaround times are of the utmost importance and the contractor will receive a higher level of evaluation grade for meeting these times. To meet these needs the contractor is required to be no more than 1 hour from pick-up at MVAHCS Laboratory to arrival at the contractor s laboratory for testing. The contractor s laboratory must be able to provide services Monday through Sunday 24 hours a day. Contractor shall provide laboratory testing services to include: List of tests with reference ranges, specimen requirements, processing and analysis of the specimen; and reporting of stat specimen results through a phone call within 4 hours of carrier pickup (carrier pick up is expected with 30 minutes of requesting) and a faxed copy sent to the Minneapolis VA laboratory following the called results. Consultation regarding selection, collection, transportation and result interpretation shall also be provided when required. The contractor must provide the following services: (a) Provide the following for transport of the specimens to include: (1) Lab test request forms (it is possible that vendor may need to customize forms to include information required by MVAHCS) (2) Special instructions for handling of specimen. (3) Specimen collection supplies for specialized testing. (4) Provide the courier service for transport of specimens. (b) Analyze samples. (c) Contractor shall provide a monthly billing for tests provided each month following the month in which the service was delivered. (d) Contractor shall consult with MVAHCS Laboratory personnel on test results by telephone as needed. (e) Provide the MVAHCS Laboratory with a means of communication to permit immediate inquiry regarding the status of a pending test. 3. A. Schedule of items (testing needs of MVAHCS): CPT CODE Description/Part Number* 84311 Adenosine Deaminase, Pericardial 80150 Amikacin Level 80335 Amitriptyline/Nortriptyline 86334 Beta-2 Transferrin 81370 HLA ABDssop (BMT HLA DR/DQ) Panel 81376 (x3) HLA-LowRes Class II 1 Loci 86162 Complement CH50, Total 82595 Cryoglobulin, Quantitative 86334 Cryoglobulin Identification 80158 Cyclosporin 80169 Everolimus 83520 Granulocyte Colony Stimulating Factor 83520 Granulocyte Macrophage CS Factor 86828 HLA PRA (Screen) 86832 HLA PRA (Class 1) 86833 HLA PRA (Class 2) 80299 Methotrexate 82657 Porphobilinogen Deaminase, RBC 80188 Primidone 80192 Procainamide & N-Acetylprocainamide (NAPA) 80194 Quinidine 80195 Sirolimus 80299 Sulfonylurea Screen 80197 Tacrolimus 80200 Tobramycin 82710 Fat, Feces, Quantitative, Timed Collection 82705 Fat, Feces, Qualitative, Random Collection 85307 Activated Protein C 85379 D-Dimer, Quantitative 85260 Factor 10, Chromogenic 85270 Factor 11 Activity 85280 Factor 12 Activity 85240 Factor 8 Activity 85250 Factor 9 Activity 85210 Factor 2 Activity 85220 Factor 5 Activity 85230 Factor 7 Activity 85260 Factor 10 Activity 85384 Fibrinogen Activity 85520 Arixtra (Fondaparinux) Assay 86022 Heparin Induced Thrombocytopenia 85520 Heparin (10a) Level 85730 (PTT) Lupus Anticoagulant Panel 85732 (PTT Mix) 85597 (PLTNEU) 85613 (DRVVT Screen) 85613 (DRVVT Mix) 85613 (DRVVT Confirm) 85525 (Hepzyme if required) 85420 Plasminogen Activity 85576 Platelet Aggregation Tests 85576 Col/EPI Platelet Function Closure Time 85576 Col/ADP if performed Reflex: Platelet Function Closure Time ADP 85730 Partial Thromboplastin Time (PTT) 85610 Protime/INR 85670 Thrombin Time 85576 Platelet Function P2Y12 (Verify Now) 85335 (Bethesda assay) Bethesda Assay for Factor 8 with Normal Plasma 85335 (Bethesda assay) Bethesda Assay for Factor 9 with normal plasma 87801 Bordetella pertussis/parapertussis PCR 87496 Cytomegalovirus qual PCR (CSF) 87496 Cytomegalovirus qual PCR (Bone Marrow) 87497 Cytomegalovirus quantitative PCR 87498 Enterovirus PCR (CSF) 87799 Epstein-Barr Virus PCR 87529x2 Herpes Simplex Culture w/typing test 87529x2 Herpes Simplex Virus PCR test (CSF) Influenza A & B culture and rapid test 87109 Mycoplasma Culture test 87109 Ureaplasma culture test 87633 Respiratory Virus Panel test (PCR, extended) 87798 Varicella-Zoster Virus PCR test -non blood 87252 Viral Culture-Non-Respiratory 87253 Viral Culture-non-Respiratory Reflex to ID 87252 Viral Culture-Respiratory 87253 Viral Culute-Respiratory Reflex to ID 87798 Varicella-Zoster Virus PCR test Qualitative (Blood) 87254 Viral Culture, Rapid Resipratory Fondaparinux Stat Fondaparinux (Additional $200 for stat) 87624 Human Papillomavirus Detection HPVMD 88342 TC initial, ImmunohistoChemistry stain 88343 TC additional, ImmunohistoChemistry stain Neuropathological Gross Exam 88312 Organism Stain (group 1) 88312-26 Organism Stain (group 1), interp. 88313 Organism Stain (group 2) 88313-26 Organism Stain (group 2), interp. 88323 Path block consult PC 88323 Path Consult & Report w/slide prep 88321 Path Consult & Report, Outside Cases (Brains) 88321 Review Outside Slides Pro Free 6051014 Doctor Neuropathology Autopsies 88231 Specialized Consulti with Dr. Snover specifically- Review outside slides (TC & PF Charges) 88235 Path Comprehensive Consult with Dr. Snover Specifically 36832 PRA Single Antigen, IgG Glass I and Class II 86833 PRA Single Antigen, IgG Glass I and Class II LAB6605 Epidermal Nerve fiber Density 85246 Von Willebrand Factor Activity 85290 Factor 13 Antigen Subunit A 83520 Interleukin-5 by Multiplex Bead Assay 83945 Oxalate 835202x2 Interleukin 3 LAB6605 ENF: Skin Biopsy for Nerve Density; Confocal microscopy 85290 Factor XIII Activity-TC 2006182 83051 Hemoglobin, Plasma Misc Misc line item used for rare occurance <1x/year, or new tests that have been developed and not on contract yet. Responses to this sources sought notice must include the following information. 1. General Information of your company name, address, contact person name, phone number, fax number, e-mail address(s) and DUNS number and company website if available. 2. Socio-economic status of business (i.e. SDVOSB/VOSB, Small Business, Large etc.) 3. Are you, or have you provided specialized laboratory testing and consultation services. If so, please provide contract number(s) for the previous three (3) years. 4. Will your company enter into a joint venture or other relationship in order to provide this service? Responses to this market survey shall be e-mailed (only) to the attention of Daniel Vagts, daniel.vagts@va.gov. No telephone responses will be accepted. Responses must be received no later than 3:00 pm CST April 29, 2019. No solicitation document is available currently; this notice is to acquire information only. Vendors interested in providing an offer will have to respond to a solicitation announcement that shall be published separately. NOTE: THIS NOTICE WAS NOT POSTED TO FEDBIZOPPS ON THE DATE INDICATED IN THE NOTICE ITSELF (24-APR-2019); HOWEVER, IT DID APPEAR IN THE FEDBIZOPPS FTP FEED ON THIS DATE. PLEASE CONTACT 877-472-3779 or fbo.support@gsa.gov REGARDING THIS ISSUE.
- Web Link
-
Link To Document
(https://www.fbo.gov/spg/VA/MiVAMC618/MiVAMC618/36C26319R0016/listing.html)
- Record
- SN05291244-F 20190426/190424230017 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |